Viewing Study NCT01896102


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-21 @ 10:11 PM
Study NCT ID: NCT01896102
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2013-03-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)
Sponsor: Genetix Biotherapeutics Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ALD-102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators